These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 29359155)

  • 41. Xpert(®) MTB/RIF detection of rifampin resistance and time to treatment initiation in Harare, Zimbabwe.
    Metcalfe JZ; Makumbirofa S; Makamure B; Sandy C; Bara W; Mason P; Hopewell PC
    Int J Tuberc Lung Dis; 2016 Jul; 20(7):882-9. PubMed ID: 27287639
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Rapid diagnosis of pulmonary tuberculosis in African children in a primary care setting by use of Xpert MTB/RIF on respiratory specimens: a prospective study.
    Zar HJ; Workman L; Isaacs W; Dheda K; Zemanay W; Nicol MP
    Lancet Glob Health; 2013 Aug; 1(2):e97-e104. PubMed ID: 25104164
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Impact of replacing smear microscopy with Xpert MTB/RIF for diagnosing tuberculosis in Brazil: a stepped-wedge cluster-randomized trial.
    Durovni B; Saraceni V; van den Hof S; Trajman A; Cordeiro-Santos M; Cavalcante S; Menezes A; Cobelens F
    PLoS Med; 2014 Dec; 11(12):e1001766. PubMed ID: 25490549
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Direct detection of Mycobacterium tuberculosis and drug resistance in respiratory specimen using Abbott Realtime MTB detection and RIF/INH resistance assay.
    Tam KK; Leung KS; To SW; Siu GK; Lau TC; Shek VC; Tse CW; Wong SS; Ho PL; Yam WC
    Diagn Microbiol Infect Dis; 2017 Oct; 89(2):118-124. PubMed ID: 28780247
    [TBL] [Abstract][Full Text] [Related]  

  • 45. An evaluation of the Xpert MTB/RIF assay and detection of false-positive rifampicin resistance in Mycobacterium tuberculosis.
    Williamson DA; Basu I; Bower J; Freeman JT; Henderson G; Roberts SA
    Diagn Microbiol Infect Dis; 2012 Oct; 74(2):207-9. PubMed ID: 22819240
    [TBL] [Abstract][Full Text] [Related]  

  • 46. GeneXpert MTB/RIF on bronchoalveolar lavage samples in children with suspected complicated intrathoracic tuberculosis: a pilot study.
    Walters E; Goussard P; Bosch C; Hesseling AC; Gie RP
    Pediatr Pulmonol; 2014 Nov; 49(11):1133-7. PubMed ID: 24339262
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of reliance on Xpert MTB/RIF on time to treatment and multidrug-resistant tuberculosis treatment outcomes in Tanzania: a retrospective cohort study.
    Mollel E; Lekule I; Lynen L; Decroo T
    Int Health; 2019 Nov; 11(6):520-527. PubMed ID: 30806660
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Are WHO approved nucleic acid amplification tests causing large-scale "false identification" of rifampicin-resistant tuberculosis?: Programmatic experience from south india.
    Sanker P; Ambika AP; Santhosh VT; Kottuthodi RP; Balakrishnan R; Mrithunjayan SK; Moosan H
    Int J Mycobacteriol; 2017; 6(1):21-26. PubMed ID: 28317800
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparison of the Xpert MTB/RIF Assay and Real-time PCR for the Detection of Mycobacterium tuberculosis.
    Kim MJ; Nam YS; Cho SY; Park TS; Lee HJ
    Ann Clin Lab Sci; 2015; 45(3):327-32. PubMed ID: 26116598
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Prevalence of drug-resistant tuberculosis in Zimbabwe: A health facility-based cross-sectional survey.
    Timire C; Metcalfe JZ; Chirenda J; Scholten JN; Manyame-Murwira B; Ngwenya M; Matambo R; Charambira K; Mutunzi H; Kalisvaart N; Sandy C
    Int J Infect Dis; 2019 Oct; 87():119-125. PubMed ID: 31357057
    [TBL] [Abstract][Full Text] [Related]  

  • 51. False-positive rifampin resistant results with Xpert MTB/RIF version 4 assay in clinical samples with a low bacterial load.
    Ocheretina O; Byrt E; Mabou MM; Royal-Mardi G; Merveille YM; Rouzier V; Fitzgerald DW; Pape JW
    Diagn Microbiol Infect Dis; 2016 May; 85(1):53-5. PubMed ID: 26915638
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Xpert MTB/RIF for diagnosis of tuberculosis and drug-resistant tuberculosis: a cost and affordability analysis.
    Pantoja A; Fitzpatrick C; Vassall A; Weyer K; Floyd K
    Eur Respir J; 2013 Sep; 42(3):708-20. PubMed ID: 23258774
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Molecular detection of rifampicin resistance by GeneXpert
    Rahman H; Khan SU; Khan MA; Qasim M; Jabbar A; Noor S; Khan Z; Khan TA; Hussain M; Muhammad N; Ali N
    J Glob Antimicrob Resist; 2017 Jun; 9():118-120. PubMed ID: 28501582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diagnostic performance and impact of routinely implemented Xpert® MTB/RIF assay in a setting of high incidence of drug-resistant TB in Odessa Oblast, Ukraine.
    Nikolayevskyy V; Kontsevaya I; Nikolaevskaya E; Surkova E; Samchenko S; Esipenko S
    Clin Microbiol Infect; 2019 Aug; 25(8):1040.e1-1040.e6. PubMed ID: 30590114
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Xpert® MTB/RIF for national tuberculosis programmes in low-income countries: when, where and how?
    Trébucq A; Enarson DA; Chiang CY; Van Deun A; Harries AD; Boillot F; Detjen A; Fujiwara PI; Graham SM; Monedero I; Rusen ID; Rieder HL
    Int J Tuberc Lung Dis; 2011 Dec; 15(12):1567-72. PubMed ID: 22005110
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The diagnostic utility of line probe assays for multidrug-resistant tuberculosis.
    Ninan MM; Gowri M; Christopher DJ; Rupali P; Michael JS
    Pathog Glob Health; 2016; 110(4-5):194-9. PubMed ID: 27499239
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Evaluation of Xpert(®) MTB/RIF assay: diagnosis and treatment outcomes in rifampicin-resistant tuberculosis.
    Kim YW; Seong MW; Kim TS; Yoo CG; Kim YW; Han SK; Yim JJ
    Int J Tuberc Lung Dis; 2015 Oct; 19(10):1216-21. PubMed ID: 26459536
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Upfront Xpert MTB/RIF for diagnosis of pediatric TB-Does it work? Experience from India.
    Kalra A; Parija D; Raizada N; Sachdeva KS; Rao R; Swaminathan S; Khanna A; Chopra KK; Hanif M; Singh V; Umadevi KR; Sheladia KN; Rao R; Vasundhara N; S A; A R N; Azeem A; Chhajlani V; Khurana J; Das NJ; Choudhury B; Nair SA; Mall S; Sen R; Chadha SS; Denkinger CM; Boehme C; Sarin S
    PLoS One; 2020; 15(8):e0236057. PubMed ID: 32756559
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Diagnostic accuracy of Xpert MTB/RIF Ultra for tuberculous meningitis in a clinical practice setting of China.
    Huang M; Wang G; Sun Q; Jiang G; Li W; Ding Z; Jia H; Gao M; Huang H; Li Q
    Diagn Microbiol Infect Dis; 2021 May; 100(1):115306. PubMed ID: 33516988
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Upfront Xpert MTB/RIF testing on various specimen types for presumptive infant TB cases for early and appropriate treatment initiation.
    Raizada N; Khaparde SD; Rao R; Kalra A; Sarin S; Salhotra VS; Swaminathan S; Khanna A; Chopra KK; Hanif M; Singh V; Umadevi KR; Nair SA; Huddart S; Tripathi R; Surya Prakash CH; Saha BK; Denkinger CM; Boehme C
    PLoS One; 2018; 13(8):e0202085. PubMed ID: 30161142
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.